Sandy Alcantara

The Marlins have informed Sandy Alcantara that they will not trade him during the upcoming offseason, reports Craig Mish of SportsGrid (X link). Mish writes that the Fish are hopeful that the 2022 NL Cy Young winner will be ready to take the ball for them on Opening Day.

Alcantara missed this entire season after undergoing Tommy John surgery in October. That was the first major blow in what has turned out to be a very difficult 12 months at loanDepot Park. Eury Pérez went down with a Tommy John procedure of his own a week into the ’24 season. The Marlins got 12 inconsistent starts out of Jesús Luzardo; his season is over due to a stress reaction in his back. A finger injury has interrupted what might have been a step forward from Ryan Weathers. Lefty Braxton Garrett is currently down with a flexor strain and has made all of seven starts. Edward Cabrera lost a couple months in the first half.

A rotation with a fully healthy Alcantara, Luzardo, Pérez, Garrett and Weathers would probably be a top 10 group in MLB. The Marlins have instead lost them all for significant chunks of the season. Between that brutal stretch of starting pitching injuries and one of the worst lineups in the majors, the Marlins have had a nightmare of a year. They started 0-9, never got back to .500, and are fully amidst a rebuild. Miami shipped out Jazz Chisholm Jr., Luis Arraez, Josh Bell, Trevor Rogers, Tanner Scott, Bryan De La Cruz and a few others as part of a roster overhaul. First-year president of baseball operations Peter Bendix has begun to reshape the front office, and it’s widely believed that manager Skip Schumaker and the organization could part ways at season’s end.

That upheaval means there aren’t many players whom the Marlins would probably steadfastly refuse to discuss in trade talks. That said, it never seemed especially likely they’d deal Alcantara next winter. He’s rehabbing a major arm procedure that at least clouds his trade value. While there’d surely still be interest if the Marlins shopped him, other teams would presumably want to price in some kind of discount in case Alcantara doesn’t regain his pre-surgery form.

There’s little reason for the Marlins to entertain diminished trade offers. Miami signed Alcantara to a $56MM extension the year before his Cy Young campaign. He’s under contract for another two seasons and the team holds an option for 2027. Alcantara is making $9MM this year. His salaries will jump to $17MM annually for the next two seasons; the option is valued at $21MM and comes with a $2MM buyout. (He’d also receive a $1MM assignment bonus if the Marlins trade him at any point.) From here forward, it’s a two-year, $36MM guarantee that comes with a third-year club option.

Despite the surgery, that’s good value for a pitcher of Alcantara’s caliber. Bounceback starters like Frankie Montas, Jack Flaherty and Luis Severino signed for between $13MM and $16MM in free agency last offseason. They all inked one-year deals, but that allowed them all to retest free agency in search of a much bigger contract if they returned to form. Alcantara is coming from a higher baseline than that trio of pitchers. If he looks anything like his old self, the final guaranteed season and the club option would be well below market value.

It’s a relatively costly commitment by Miami’s standards, but the Marlins have little else on the books next year. They owe the already released Avisaíl García $17MM between his $12MM salary and a $5MM buyout on his 2026 option. They’re responsible for $10MM annually to the Yankees between 2026-28 on the Giancarlo Stanton contract. Minor league reliever Woo-Suk Go, who is owed $2.75MM next season between his salary and a ’26 option buyout, is the only other player on a guaranteed deal beyond this season.

Luzardo, Jesús Sánchez and Garrett headline what’ll be a relatively light arbitration class. The Fish aren’t likely to do much in free agency after spending all of $5MM last winter on a one-year deal for Tim Anderson. Even with Alcantara’s salary rising by $8MM, they could open next season with a lower player payroll than their approximate $92MM mark this year (calculated by Cot’s Baseball Contracts).

If Alcantara performs well in the first half, he could be one of the most in-demand players at next summer’s deadline. Even if all their starters come back healthy, Miami will be hard-pressed to compete barring a major lineup overhaul. The Marlins still may not want to move Alcanatara with the amount of time remaining on his deal, but that’d be a more interesting question for the front office than it would to sell low on him over the offseason.

Marlins star Sandy Alcantara underwent Tommy John surgery, he announced on Instagram. The procedure, performed by Dr. Keith Meister, occurred this morning. He’ll miss the entire 2024 season.

“With a heavy heart, I want to let everyone know I had Tommy John surgery today and will miss next season,” the 2022 NL Cy Young winner wrote as part of a statement. “I am most saddened for the great Marlins fans, who were so supportive of me and the team this year. The drive to the playoffs was thrilling for all of us.”

While the Marlins hadn’t indicated that surgery was on the table, it’s not an especially surprising development. Alcantara’s season was cut short last month. He landed on the injured list on September 6 with what the team initially diagnosed as a flexor strain. That was later revised to a UCL sprain, indicating some measure of tearing within the elbow ligament. With the Fish making a playoff push, Alcantara tried to return at season’s end. He threw four innings in a Triple-A rehab outing but reported additional forearm discomfort coming out of that appearance. Miami shut him down at that point.

The Fish were able to get into the postseason even without Alcantara contributing in the last few weeks. After being swept in the Wild Card round by the Phillies, they’ll go into the offseason looking for ways to build off this year’s promise. That’ll be quite a bit more difficult without one of the sport’s preeminent workhorses.

No pitcher has thrown more innings than Alcantara’s 619 over the last three seasons. Only Gerrit Cole has taken a heavier workload going back to the start of 2019. Alcantara handily leads the majors in complete games over the last three years, finishing off 10 starts. No other pitcher has gone the distance more than six times.

The two-time All-Star combines that MLB-best volume with outstanding rate production. He posted a sub-4.00 ERA every year from 2019-22, highlighted by a sterling 2.28 earned runs allowed per nine last season. He was unanimously voted the Senior Circuit’s top pitcher. Alcantara wasn’t as dominant this year, though he turned in another effective season overall. In 28 starts, he worked to a 4.14 ERA behind a 52% grounder rate while averaging over six and a half innings per appearance.

At this time last year, the Marlins had an embarrassment of riches on the mound. That contributed to their decision to deal Pablo López for Luis Arraez in an effort to balance the roster. Miami has to be thrilled with what they received from Arraez in his first season in South Florida. While they still have a good rotation, its depth has taken some notable hits.

Trevor Rogers made just four starts, none after April, because of a left biceps strain and a partial tear in his right (non-throwing) lat muscle. Prospect Jake Eder was dealt midseason for third baseman Jake Burger. Hard-throwing righty Edward Cabrera walked over 15% of major league opponents and was demoted to Triple-A for a month midseason. He managed a 4.24 ERA behind a strong 27.3% strikeout percentage. Miami’s starting staff ranked 9th in the majors in ERA (4.10), an effective yet hardly dominant result.

Left-handers Jesús Luzardo and Braxton Garrett each topped 30 starts with sub-4.00 ERA showings. Top prospect Eury Pérez worked to a 3.15 ERA while striking out nearly 29% of batters faced in 19 outings as a rookie. They project as the top three in next year’s staff, likely followed by Cabrera and Rogers. Former #3 overall pick Max Meyer should be ready for Spring Training after missing all of this year working back from Tommy John surgery of his own.

There’s significant ceiling in that group, but only Luzardo and Garrett have shouldered a full big league workload within the last two seasons. The club could be cautious with innings counts for any of Pérez, Rogers or Meyer. Ryan Weathers and Bryan Hoeing currently stand as the top depth options.

It seems likely Miami will bring in a veteran arm to add some stability to the group. They hoped that last winter’s signing of Johnny Cueto to an $8.5MM free agent deal would lock in serviceable back-of-the-rotation innings. Cueto didn’t meet expectations and is headed back to the open market. GM Kim Ng and her staff could look for a similar addition this time around.

Alcantara will count against the 40-man roster throughout the offseason. Miami can place him on the 60-day injured list at the beginning of Spring Training. As part of the extension he signed in November 2021, he’ll make $9MM next season. Alcantara is under contract for $17MM annually between 2025-26. Miami has a $21MM option or a $2MM buyout for the ’27 season.

TODAY: Unsurprisingly, Alcantara confirmed today that he won’t pitch again in 2023.  “That’s the thing that broke my heart.  I won’t be able to go out there with my teammates and compete….Hopefully we make it to the playoffs without me. [I’ve] just gotta be here and support them,” Alcantara told Jordan McPherson and Andre C. Fernandez of the Miami Herald.

The Cy Young Award winner said that he and his agent haven’t yet met with Marlins management to discuss what’s next, whether that’s more rehab or whether or not Alcantara might require some kind of surgery.

SEPTEMBER 22: Defending NL Cy Young winner Sandy Alcantara has been on the injured list since September 6. He was diagnosed with a sprain in the UCL of his throwing elbow last week but had still been attempting to make it back for the team’s playoff push.

Alcantara made a rehab outing with Triple-A Jacksonville last night. He got through four scoreless innings but informed the team after the game that he’d experienced renewed forearm tightness (relayed by Jordan McPherson of the Miami Herald). He’ll likely be pulled off his rehab stint and rejoin the team this weekend while remaining on the IL.

The club hasn’t announced a timetable or the next steps in Alcantara’s recovery. They’ll surely proceed with caution with the star right-hander, which raises the question of whether they could decide to shut him down for the season. While Alcantara and the team clearly hoped he’d be able to pitch through the injury, the diagnosis of a UCL sprain inherently means there’s some degree of stretching or tearing in that ligament.

Alcantara hasn’t replicated last year’s success, when he threw an MLB-high 228 2/3 innings with a sterling 2.28 ERA. He has still been an effective rotation member for the Fish, allowing 4.14 earned runs per nine across 184 2/3 frames. Alcantara owns a 3.20 ERA since the All-Star Break while averaging nearly 6 2/3 innings per start.

Miami has been without Trevor Rogers for the majority of the season. They’re relying on Jesús Luzardo, Braxton Garrett, highly-touted rookie Eury Pérez and Edward Cabrera in the rotation. They turned to a bullpen game for the final spot in today’s series opener with the Brewers. That hasn’t worked, with Steven Okert and Bryan Hoeing tagged for a combined 12 runs before getting out of the second inning.

A loss tonight will drop the Fish a game behind the Cubs for the last Wild Card spot in the National League. The Reds could jump a half-game ahead of Miami if they beat the Pirates. Miami will turn to Luzardo and Cabrera for the final two games against the Brew Crew. They’re off on Monday before finishing their season with road games in six consecutive days against the Mets and Pirates.